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Abstract
Background
Globally, over 800 000 children under five die each year from infectious diseases caused by
Streptococcus pneumoniae. To understand genetic relatedness between isolates, study
transmission routes, assess the impact of human interventions e.g. vaccines, and deter-
mine infection sources, genotyping methods are required. The ‘gold standard’ genotyping
method, Multi-Locus Sequence Typing (MLST), is useful for long-term and global studies.
Another genotyping method, Multi-Locus Variable Number of Tandem Repeat Analysis
(MLVA), has emerged as a more discriminatory, inexpensive and faster technique; however
there is no universally accepted method and it is currently suitable for short-term and local-
ised epidemiology studies. Currently Australia has no national MLST database, nor has it
adopted any MLVA method for short-term or localised studies. This study aims to improve
S. pneumoniae genotyping methods by modifying the existing MLVA techniques to be more
discriminatory, faster, cheaper and technically less demanding than previously published
MLVA methods and MLST.
Methods
Four different MLVA protocols, including a modified method, were applied to 317 isolates of
serotyped invasive S. pneumoniae isolated from sterile body sites of Queensland children
under 15 years from 2007–2012. MLST was applied to 202 isolates for comparison.
Results
The modified MLVA4 is significantly more discriminatory than the ‘gold standard’MLST
method. MLVA4 has similar discrimination compared to other MLVA techniques in this
study). The failure to amplify particular loci in previous MLVA methods were minimised in
MLVA4. Failure to amplify BOX-13 and Spneu19 were found to be serotype specific.
Conclusion
Wehavemodified a highly discriminatory MLVA technique for genotyping Queensland invasive
S. pneumoniae. MLVA4 has the ability to enhance our understanding of the pneumococcal
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epidemiology and the changing genetics of the pneumococcus in localised and short-term
studies.
Introduction
More than 800 000 children under five succumb to invasive pneumococcal diseases (IPD) each
year globally [1]. Australia is not exempt from invasion with 6.7 per 100 000 notifications in
2013 [2–3]. IPD are defined as the isolation of S. pneumoniae from normally sterile body sites
including blood, tissues, and cerebrospinal, joint, pericardial or pleural fluids [4]. The changing
pneumococcal population structure worldwide is largely the result of serotype replacement and
capsule switching, especially in first world countries such as Australia where vaccines are wide-
ly implemented [5–7]. Serotype replacement has been problematic as current pneumococcal
vaccines only target 13 out of 95 pneumococcal serotypes [8–13]. Capsule switching, the trans-
fer of a capsule genes from one pneumococcus to another, is a regular occurrence in pneumo-
coccal populations however it has the potential to reduce vaccine efficacy because vaccine
escape isolates can emerge [6–7]. Vaccine escape isolates can develop within 2–3 years of a vac-
cine introduction, as already detected in the USA and Italy [6, 14]. In vitro studies have demon-
strated that capsule switching can also impact pneumococcal virulence properties, particularly
since the polysaccharide capsule is a virulence factor of pneumococci [8]. A highly virulent cap-
sule type 5 strain was rendered avirulent when expressing a capsule type 3 and a type 6A strain
expressing a capsule type 6C was more virulent than wild types [15–16].
So far, there have been little published studies examining the pneumococcal population
structure in Australia since the introduction of the new vaccine 13-valent pneumococcal conju-
gate vaccine in July 2011 [17].
For decades, the main technique for surveying serotype distribution and replacement has in-
volved serotyping pneumococci with antisera (such as the Quellung reaction) [18]. However
serotyping is expensive, laborious, and ambiguous, revealing no information about genetic re-
combination and capsule switching. Therefore several genotyping methods have been devel-
oped, including MLST [19] and several MLVA techniques [20–23]. It is important to bear in
mind that genotyping and serotyping are both required in combination to detect capsule
switching events.
Commonly, MLST is used to genotype S. pneumoniae based on the original technique in-
volving housekeeping genes developed by Enright and Spratt [19]. MLST housekeeping genes
are considered to be stable and less prone to recombination than the rest of the genome, en-
abling examination of long-term population changes and studies across wider areas [19]. How-
ever, MLST is expensive and laborious, not suitable for large-scale genotyping or routine use
[20–21, 24–27]. There is no national Australian MLST database, and the international MLST
database only contains 138 Australian isolates from the year 1967 to 2013, providing very little
information regarding the Australian pneumococcal population. The international MLST data-
base could be used as a comparison against the pneumococcal isolates found in the rest of
the world.
To reduce cost and labour intensity, MLVA was developed for genotyping S. pneumoniae. It
is reported to be more discriminatory, inexpensive and faster than MLST, however more suit-
able for short-term epidemiology changes and localised outbreaks [20–21, 27]. MLVA involves
amplifying Variable Number of Tandem Repeats (VNTR) loci and sizing the PCR products ac-
cording to fragment lengths. VNTRs are suitable genotyping targets since there are multiple
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loci throughout the genome and they are polymorphic [28]. MLVA can be multiplexed, and
uses a DNA sequencer for high throughput analysis of fragment sizes, not sequencing [25].
Different MLVA protocols exist including Koeck’s et al. [21] MLVA which amplifies seven-
teen VNTRs, each in a singleplex PCR. This method was used to genotype pneumococcal iso-
lates in Burkina Faso [29]. Unfortunately the practicality of typing seventeen targets and the
difficulty comparing analysis of gels are some of the limitations. There is a freely accessible da-
tabase (http://mlva.u-psud.fr/mlvav4/genotyping/index.php - Simple Databases labelled ‘Strep-
tococcus pneumoniae2005) which allows comparison of profiles, however there are only 59
isolates available in this database. Recently this protocol has been modified by Van Cuyck et al.
[22] by reducing the number of VNTRs to seven, which were experimentally determined to
have the highest discrimination (Hunter-Gaston Diversity>0.8) within a population of 331
UK isolates. This seven marker MLVA is claimed to be a minimum universal set, ideal for gen-
otyping pneumococcal isolates. However it is known that pneumococcal populations differ be-
tween countries, therefore the selection of these seven MLVAmarkers may not be suitable for
Australian isolates.
Another MLVA protocol was developed by Elberse et al. [20], which utilises eight BOX
VNTR loci amplified in two multiplex PCRs with fluorescently labelled probes. BOX loci are a
type of VNTR loci, distinguishable by varying numbers of boxB repeat regions (45 base-pair)
found between boxA and boxC which remain stable under laboratory conditions [20, 30]. BOX
elements can form secondary structures and can affect the expression of downstream genes
[31]. Elberse’s method solely uses BOX loci (no other VNTR), while Koeck’s method uses a
combination of BOX loci and other VNTR loci, which do not contain stable boxA and boxC
units, and vary in repeat lengths e.g. 60 base-pair. Elberse’s MLVA protocol has been applied to
genotype pneumococci in the Netherlands and carriage isolates from Portugal, as well as track-
ing a localised outbreak in England [32]. However, a limitation is that some BOX loci fail to
amplify (assigned ‘99’) therefore leaving profiles incomplete, an issue that remains unresolved.
An MLVA type can still be assigned even if the profile contains a non-amplified locus (studies
from Elberse identify that 89% of serotype 7F isolates will commonly have a BOX-06 that
won’t amplify). The limitation of having an incomplete genetic profile is that we can’t see the
‘true’ bacterial fingerprint of the isolate. It is unknown whether this could have implications for
population studies.
Finally, Multi-Locus boxB Typing (MLBT) was developed, a variation of MLVA by sequenc-
ing VNTR loci to detect Single Nucleotide Polymorphisms (SNPs) as well as fragment length
variations [23]. MLBT contains VNTRs that have been used in the other MLVA protocols,
however the complexities of MLBT does not enable ease of comparison with other MLVA
methods [20–21, 23].
The aim of this study was to improve pneumococcal genotyping methods by modifying ex-
isting MLVA. It is important to modify the existing MLVAmethods to be more discriminatory,
faster, cheaper and technically less demanding than previously published MLVA methods and
MLST.
Methods
Setting
All pneumococcal isolates from Queensland patients with IPD are required to be submitted to
the Public Health Microbiology Laboratory at Queensland Health Forensic and Scientific Ser-
vices (QHFSS), Brisbane. Serotyping (Quellung) is mandatory, however further genotyping has
only been performed for research purposes. Invasive S. pneumoniae isolates taken from
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normally sterile body sites were serotyped by the Pneumococcal Reference Laboratory, QHFSS,
using Quellung reaction [4, 18].
Laboratory methods
S. pneumoniae isolates were cultured 16-streak on Horse Blood Agar (HBA, Oxoid, Australia—
a commercially available product routinely used for the culture of bacteria). A single colony
was re-cultured on fresh HBA to ensure isolates were genetically identical. Isolates were boiled
in 400μL TE buffer (~pH8.0) for eight minutes to prepare a thermolysate with template DNA
and were stored at -20°C until further use.
MLVAmarkers were selected from previously published papers [20–23]. All MLVA mark-
ers were analysed in silico to determine the expected fragment sizes and copy numbers against
known S. pneumoniae genomes from the NCBI database (R6, G54, CGSP14, TIGR4 and Hun-
gary19A-6).
S. pneumoniae isolates (n = 317) detected in Queensland were genotyped using MLVA1,
MLVA2 and MLVA4. Elberse’s MLVA1 contained two multiplexes with eight BOX genes
(Table 1) [20]. The MLVA2 procedure was based on Van Cuyck’s MLVA method and con-
tained seven VNTRs (Table 1) [22]. A single multiplex reaction was performed with Spneu17,
Spneu19, Spneu27 and Spneu39 as the other three had already been typed in MLVA1. Spneu31
[21] and B10 [23] were separately amplified to determine whether they provided high discrimi-
nation within the pneumococcal population, and therefore suitable for the modified
MLVAmethod.
MLVA4 was the modified MLVAmethod based on the high discrimination of the fourteen loci
previously used, and the ability to amplify all loci across the different serotypes detected in Queens-
land [20–23]. Three multiplexes were developed (Table 1). Four primer sets were redesigned due
to difficulties in amplification, including BOX-12 (F: GAGATTGCCCTTTTCATCTTCG; R:
AGCAACCATTGAAACGCCTG), BOX-13 (F: TCAAAAGATTGGAGAGTTCCGC; R:
GGATTTGGAGAGCAAGCAGATC), Spneu19 (F: CACTCACCGTTAGCATTGACTCG; R:
TAATCAGGGAGTAGTTGGTTGGG) and B10 (F: GGAGCCGAGTAGGAGATTCTCAC; R:
TCGTAGGCTGCTACATTGACCAG) (Geneworks, Australia).
The Corbett Cas1200 Robotic system was used to prepare mastermix with DNA thermoly-
sate. The PCR protocol was optimised and consisted of 15min at 95°C, 30 cycles of 95°C for
30sec, 58°C for 60sec and 72°C for 60sec, followed by extension of 72°C for 10min and held at
4°C. Diluted PCR products (1:150 reverse-osmosis water (PALL, Australia)) were combined
with 1200LIZ internal ladder (Applied Biosystems, Australia). A heat denaturation step (95°C
for 5min, followed by a hold step at 4°C) was performed on a thermocycler to separate the
dsDNA. Fragment sizing was performed on AB3130 (Applied Biosystems, Australia).
Table 1. Multiplex arrangement for MLVAmethods.
Genotyping method Multiplex number Loci Reference
MLVA1 1 BOX-01, BOX-02, BOX-03, BOX-04 [20]
2 BOX-06, BOX-11, BOX-12, BOX-13 [20]
MLVA2 1 Spneu17, Spneu19, Spneu27, Spneu39 [22]
2 Spneu25, Spneu33, Spneu37 [22]
MLVA4 1 BOX-01, B10, Spneu19, Spneu39 This study
2 BOX-12, BOX-13 This study
3 BOX-02, BOX-03, BOX-04, Spneu17 This study
doi:10.1371/journal.pone.0121870.t001
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Finally, MLST was also applied to selected isolates (n = 202) for comparison purposes as
previously described [19, 33].
Analysis
PeakScanner V1.0 software was used to analyse MLVA results (Applied Biosystems, Australia).
A MLVA type (MT) using MLVA1 was assigned to each isolate using the MLVA database
(http://www.mlva.net). MT types for MLVA2, and MLVA4 was manually assigned from our
own database. Van Cuyck et al. [22] did not provide a database or published MLVA types that
could be used in the Queensland pneumococcal population. The pneumococcal population
structure using all MLVAmethods were displayed as eBurst diagrams produced from PHYLO-
ViZ software [34]. Clonal clusters (CC) are defined as two or more isolates that are genetically
related and linked by single locus variants (SLV) or double locus variants (DLV). Where an in-
ternational or larger database is available, Queensland isolates were compared.
MLST results were analysed using ChromasPro software (Technelysium Pty Ltd.) using
batch alignment analysis. Allele numbers and sequence types (ST) were assigned to each isolate
from the MLST database (www.mlst.net) and displayed as an eBurst diagram using
PHYLOViZ software.
The Simpson’s Index of Diversity (S) was calculated to compare the discrimination of all
genotyping methods (http://darwin.phyloviz.net/ComparingPartitions/index.php?link=Tool).
If the 95% confidence intervals (CI) overlap between methods, the hypothesis that the methods
have similar discriminatory power cannot be excluded. The Adjusted Wallace coefficient (AW)
was used to measure the congruence between typing methods [35–36].
The frequency of non-amplified loci (‘99’) was compared between each MLVA method to
determine whether this was a limitation of a particular method or associated with specific sero-
types. Hunter-Gaston Diversity Index (DI) (http://www.hpa-bioinformatics.org.uk/cgi-bin/
DICI/DICI.pl) was used to calculate the genetic diversity of VNTR genes within the Queens-
land population, as used in previous studies [21–22, 37]. DI is a measure of the variation of the
number of repeats at each locus, ranging from 0.0 (no diversity) to 1.0 (complete diversity).
Ethics statement
No human participants were involved directly in this study and hence, human ethics clearance
was not required. S. pneumoniae isolates routinely cultured from clinical specimens were used
and we investigated the epidemiology of the S. pneumoniae isolates, changing genotypes and
population structure in Queensland.
Results
Comparison of genotyping methods
All 317 S. pneumoniae Queensland isolates in this study were assigned an MLVA genotype,
covering 35 serotypes detected in Queensland from 2007–2012 (serotypes include 1, 3, 4, 6A,
6B, 6C, 7F, 8, 9N, 9V, 10A, 10F, 11A, 12F, 14, 15B, 15C, 16F, 18A, 18B, 18C, 19A, 19F, 22A,
22F, 23A, 23B, 23F, 24F, 33B, 33F, 34, 35B, 35F, and 38). MLVA4 method has novel aspects as
four sets of primers and the three multiplex PCR has been newly designed in this study.
Isolates selected for MLST included 13vPCV serotypes and non-13vPCV serotypes to mini-
mise labour work and costs (excluding those originally in the 7vPCV i.e. serotype 4, 6B, 9V, 14,
18C, 19F and 23F, and serotype 19A). Studies have already shown that 7vPCV serotypes have
significantly declined [38–39], so we focused on the examination of these recently targeted or
non-targeted serotypes.
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All three MLVA genotyping methods had a higher discriminatory power compared to
MLST (Table 2). MLVA4 had a significantly higher discrimination compared to MLST
(S = 0.978 with 106 MLVA types; S = 0.936; 49 ST’s) (n = 202). In comparison, MLVA1 had a
discrimination of S = 0.963 (n = 202; 71 MLVA types) and MLVA2 had S = 0.977 (n = 202; 97
MLVA types).
However, when comparing the Adjusted Wallace Coefficient of MLVA4 with the other two
MLVAmethods, all MLVA methods had similar discriminatory power (Table 2). MLVA4 has
high congruence with MLVA1 (AW = 0.883), MLVA2 (AW = 0.766) and MLST
(AW = 0.966). This indicates that the MLVA4 genotypes will have a 96.6% probability that it
will have the same MLST type. Conversely, the congruency of MLST with MLVA4
(AW = 0.314) indicates that the MLST types will have a 31.4% probability of having the same
MLVA4 types, indicating that MLVA4 is more discriminatory.
NewMLVA1 BOX alleles were also found including BOX-04 fragment sizes 10 repeats
(n = 1), 11 repeats (n = 1) and 12 repeats (n = 3), BOX-03 fragment size 8 repeats (n = 2),
BOX-12 fragment size 0 repeats (n = 2) and BOX-13 fragment size>2000bp (unsure how
many repeats until sequenced; n = 8). There are 107 new MLVA1 MT types not recorded by
the MLVA database [25] In addition, 20 new STs have been submitted to the MLST interna-
tional database (ID#23211–23429).
VNTR loci and ‘99’
BOX-01, BOX-04, BOX-12, BOX-13 and Spneu17 had the highest diversity (DI 0.80) while
BOX-02, BOX-11, Spneu19 and Spneu27 had the lowest diversity (DI 0.66) (Table 3). When
examining MLVA1, 20.2% of isolates still contain at least one non-amplified locus. Even
MLVA2 contained 21.1% of isolates with non-amplified loci. MLVA4 method reduces the ‘99’
to 12.6% (Table 4).
Table 2. Calculation of Simpson's Index of Diversity for serotyping (Quellung), MLST, MLVA1, MLVA2 and MLVA4methods.
Total Number of S. pneumoniae isolates = 202
Molecular
method
Total number of
genotypes
Simpson’s Index of
Diversity (S)
CI (95%) Average time to genotype
48 isolates (days)
Cost per isolate (PCR to
genotype) (AUS$)
Non-amplified
loci (%)
Serotyping 29 0.912 0.893–
0.930
- - N/A
MLST 49 0.936 0.920–
0.952
16–20 346.65 N/A
MLVA1 71 0.963 0.953–
0.974
3–4 17.10 20.8
MLVA2 97 0.977 0.970–
0.985
3–4 16.37 24.3
MLVA4 106 0.978 0.971–
0.986
3–4 23.71 12.4
Total Number of S. pneumoniae isolates = 317
Serotyping 35 0.914 0.897–
0.932
- - N/A
MLVA1 163 0.984 0.980–
0.989
3–4 17.10 20.2
MLVA2 175 0.987 0.983–
0.991
3–4 16.37 21.1
MLVA4 203 0.990 0.987–
0.994
3–4 23.71 12.6
doi:10.1371/journal.pone.0121870.t002
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These VNTR loci failed to amplify in specific serotypes. BOX-06 failed to amplify 75% of se-
rotype 7F (n = 27), BOX-13 failed to amplify 42% of serotype 33F (n = 5) and 54% of serotype
6C (n = 7), Spneu19 failed to amplify 63% of serotype 3 (n = 12) and 50% of serotype 38
(n = 4), and BOX-01 failed to amplify 20% of serotype 19F isolates (n = 3) (Table 3). Spneu19
allele sequences were not found in serotype 3 genomes using BlastN (strains OXC141, SP3,
SPN021198, SPN034156, SPN034183, SPN072838, SPN994038 and SPN994039). Similarly
Spneu19 failed to amplify in serotype 38; however no serotype 38 genome has been sequenced
to date to allow us to determine whether the Spneu19 locus exists. No match was found for
BOX-13 in serotype 6C NCBI genomes, and failed to amplify in serotype 33F, however gel elec-
trophoresis showed a large>2000bp fragment (S1 Fig.). BOX-06 primers appear to anneal to a
serotype 7F contig (CDC 1087–00 contig ABFT01000005.1) however the fragment size exceeds
1200bp which would not be detected with the AB3130 internal size ladder LIZ1200. Gel elec-
trophoresis did not reveal any bands, corresponding to BOX-06 in serotype 7F.
Comparison of MLVA and MLST eBurst
MLVA4 has been shown to be vastly cheaper and faster than MLST, costing $23.71 compared
to $346.65 per isolate, respectively, and taking only 3–4 days on average to genotype 48 isolates,
compared to 16–20 days, respectively.
Comparison of MLST and our MLVA4 eBurst analysis clearly shows two different popula-
tion structures (Fig. 1). The pneumococcal population structure is displayed according to the
MLVA4 genotypes, and it is observed that there are 32 clonal clusters (CC), with the larger
eleven clusters labelled in the figure. The MLST results are overlayed on the MLVA4 results;
therefore each colour represents a different MLST type. It can be seen that several MLVA4
clusters would appear as a single MLST type, for example CC1 which predominantly contains
serotype 7F isolates has as many as ten different MLVA4 types however only one MLST type as
depicted by the single green colour of the circles.
Using MLVA4 for localised Queensland studies show that most CCs predominantly contain
a single serotype (e.g. CC1 contains serotype 7F, CC4 contains serotype 3) (Fig. 1). However
some clusters contain mixed serotypes including CC11 (serotype 19A and 19F), CC8 (serotype
15B, 15C and 19A), CC9 (serotype 18B and 18C), CC10 (serotype 1 and 4), CC3 (serotype 6A
and 6C), CC12 (serotype 8 and 11A), CC13 (serotype 33F and 22F). MLST identifies most of
these CC but many appear as a single isolates.
MLST results were also overlayed with the MLVA1 and MLVA2 results. Both MLVAmeth-
ods are more discriminatory than MLST, as evident by the diversification of MLST types into
many MLVA types (e.g. CC10 contains at least five different MLVA1 types with the same
MLST type) (Figs. 2 and 3). Interestingly, MLVA1 groups serotypes 1, 3 and 7F into the same
cluster (CC10) according to the genotype profile (Fig. 2). Similarly, MLVA2 groups most of the
clusters together as isolates appear to have SLV or DLV of another isolates (Fig. 3). However
Table 3. AdjustedWallace Coefficient and 95% confidence intervals (CI) for four genotyping and one serotypingmethod.
Total number of S. pneumoniae isolates = 202
MLVA1 MLVA2 MLVA4 Serotyping MLST
MLVA1 0.524 (0.461–0.5287) 0.512 (0.442–0.582) 0.940 (0.891–0.989) 0.984 (0.974–0.995)
MLVA2 0.871 (0.800–0.942) 0.739 (0.667–0.810) 0.880 (0.804–0.956) 0.916 (0.887–0.945)
MLVA4 0.883 (0.823–0.942) 0.766 (0.690–0.843) 0.918 (0.842–0.994) 0.966 (0.927–1.000)
Serotyping 0.372 (0.301–0.442) 0.209 (0.157–0.262) 0.211 (0.161–0.260) 0.648 (0.587–0.709)
MLST 0.552 (0.456–0.648) 0.309 (0.244–0.374) 0.314 (0.254–0.374) 0.919 (0.869–0.969)
doi:10.1371/journal.pone.0121870.t003
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for some serotypes, MLVA4 provides higher discrimination than MLST and the other MLVA
methods, evident by the high diversification of serotype 7F and serotype 3 (Fig. 4).
Finally, MLST and MLVA4 used in combination with serotyping can identify potential cap-
sule switching. MLST identifies seven potential capsule switches including serotypes 22F to
33F (ST1012), serotypes 18B to 18C (ST1255), serotypes 15B to 15C (ST199), serotypes 1 to 4
(ST306), serotypes 19A, 15B and 15C (ST411), serotypes 6A to 6C (ST4237) and serotypes 8 to
11A (ST53) (S1 Fig.). On the other hand, MLVA4 only detects two capsule switches including
serotypes 15C to 19A (MT59; ST411), and serotypes 1 to 4 (MT36; ST306). The Queensland S.
pneumoniae isolates are listed in the supplementary data (S1 Table) which contains MLVA1,
MLVA4, MLST and serotype for comparison.
Discussion
MLVA has emerged as an alternative genotyping technique to the ‘gold standard’MLST as it
has higher discriminatory power, is fast and inexpensive [20–21, 24]. Results in this study sup-
port this finding as MLVA4 is vastly cheaper and faster than MLST, and is still comparable to
the costs and laboratory processing time of the other published MLVAmethods (Table 2). Re-
ducing time and costs for genotyping will have an impact on the public health field by having
the ability to resolve “large and complex outbreak situations” [24].
The choice of the ten VNTRs for our MLVA4 method was based on a Hunter-Gaston Di-
versity of0.8, as well as an anchor locus with low discrimination to determine long-term
changes (BOX-02), and an extra locus with high discriminatory power for specific serotypes
(Spneu19). Of the eight highly discriminatory VNTR loci used in previously published MLVA
Fig 1. MLVA4 eBurst of Queensland invasive S. pneumoniae isolates from 2007 to 2012 (n = 317).MLST eBurst of invasive S. pneumoniae isolates
from 2007–2012 (n = 202). MLST results are overlayed (coloured circles) to allow ease of comparison against MLVA4 results. Grey circles represent isolates
that have not been assigned a MLST type. The size of the isolate circles corresponds to the number of isolates. Clonal clusters are identified in black ovals,
and those that contain predominantly one colour indicate that the isolates have a single MLST type. Isolates are labelled with MLVA4 type (MT).
doi:10.1371/journal.pone.0121870.g001
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papers, seven VNTRs are included in the modified MLVA4 method [20–23]. MLVA4 main-
tains high congruence with the other MLVAmethods and MLST (Table 2).
When comparing the different genotyping methods, MLVA4 method maintains a high dis-
criminatory power whilst minimising the number of ‘99’, and is significantly more accurate in
representing the Queensland pneumococcal population structure than MLST. Clusters of iso-
lates can be observed in more detail and can glean more information when combined with iso-
late information such as antibiotic resistance or location of disease (not investigated in this
study). Admittedly, additional markers have increased the discriminatory power when applied
to Queensland, Australian isolates however we have maintained minimal laboratory work to
three multiplexes.
MLST was proven to be less discriminatory although it could still maintain as an ideal meth-
od for long-term and international epidemiology studies. A less discriminatory protocol is
problematic if it does not detect emerging genotypes or outbreaks in a localised area or state. It
is evident that MLVA4 is more efficient at discriminating pneumococcal isolates because, for
example, MLST type 191 (serotype 7F) actually can be separated into nine different MLVA4
types (Fig. 4).
However, this study confirms the problem of failing to amplify particular loci, resulting in
incomplete genotypes. As a result, a number of primers were re-designed in this study in an at-
tempt to successfully amplify the failing loci (including BOX-10, BOX-12, BOX-13 and
Spneu19). Elberse et al. [40] reported that 24% of their isolates still contained one or more
non-amplified BOX loci even after repeated PCR. This study observed that some loci failed to
amplify in specific serotypes, for example BOX-06 failed to amplify 75% of Queensland sero-
type 7F, indicating that primers needed to be redesigned, or VNTR fragments were absent. Se-
rotype 7F (89% isolates) has been associated with a large number of non-amplified BOX-06
Fig 2. The MLVA1 eBurst diagram depicting invasive S. pneumoniae isolates from 2007 to 2012 (n = 317).MLST results are overlayed (coloured
circles) to allow ease of comparison against MLVA1 results. Grey circles represent isolates that have not been assigned a MLST type. CC are surrounded by
a black oval and contain SLV and DLV. The size of the dots corresponds to the number of isolates.
doi:10.1371/journal.pone.0121870.g002
Streptococcus pneumoniaeGenotyping by Modified MLVA
PLOSONE | DOI:10.1371/journal.pone.0121870 April 29, 2015 10 / 15
genes [40]. Since the primers for MLVA are located in stable boxA and boxC regions flanking
the boxB repeats, the difficulty in amplifying the loci is unlikely. Therefore, it is theorised that
gene elements are more likely to be lost (or acquired) if there is a higher average number of
boxB repeats [31]. It is possible that the BOX-06 region is missing from serotype 7F as there are
up to eight different BOX-06 fragment lengths. Therefore BOX-06 was not used in MLVA4
due to a high percentage of ‘99’ and a low Hunter-Gaston diversity. Serotype 7F was the second
most common serotype (9%) found in Queensland, therefore using higher discriminatory loci
was favoured.
Similarly, Spneu19 loci and BOX-13 could not be detected in serotype 3 and 33F isolates, re-
spectively. The failure to amplify Spneu19 in serotype 3 has also been observed, suggesting that
serotype 3 lack pcpA which codes for a non-essential surface protein involved in cell adhesion
[21, 41]. On the other hand, long BOX-13 fragments (>2000bp) have been identified in sero-
type 33F isolates, possibly accounting for the ‘99’ results since the AB3130 internal size ladder
only reaches 1200bp. Large fragments could be explained by the placement of an insertion se-
quence (IS) element, making the BOX element appear to be larger than 2kb. The presence of IS
elements has been described in another MLVA study [42].
Variations in interpreting the population structure of S. pneumoniae have been observed
when using different genotyping protocols. Already potential capsule switches have been ob-
served between a serotype 19A and 15C in CC8 (MT59; ST411), and a serotype 1 and 4 (MT36;
ST306) in CC10 in our Queensland population using MLVA4 (S1 Fig.). MLST also identifies
these capsule switches, as well as many others which may indicate false capsule switching since
MLST is less discriminatory to discern true genetic background of S. pneumoniae isolates.
When examining the international database, some of these capsule switches can be verified, for
Fig 3. The MLVA2 eBurst diagram depicting invasive S. pneumoniae isolates from 2007 to2012 (n = 317).MLST results are overlayed (coloured
circles) to allow ease of comparison against MLVA1 results. Grey circles represent isolates that have not been assigned a MLST type. CC are surrounded by
a black oval and contain SLV and DLV. The size of the dots correspond to the number of isolates.
doi:10.1371/journal.pone.0121870.g003
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example ST199 (serotype 19A/15C), ST1012 (serotype 22F/33F) and ST4237 (serotype 6A/6C),
however there is no support for capsule switching of the other strains in the international data-
base. This could mean that the capsule switch is relatively new. Alternatively, MLVA4 is too
discriminatory and even though true capsule switch occurs, MLVA4 identifies two distinct ge-
notypes therefore the assumption is that no capsule switching has occurred. Further investiga-
tion is required to determine whether MLVA4 could fail to detect capsule switches or that
MLST is detecting false capsule switches. Since MLVA4 is highly discriminatory, it may enable
detection of capsule switching earlier than MLST would. Accurately and quickly detecting rela-
tionships between serotypes may have an impact on the selection of serotypes for future vac-
cine strategies. Furthermore, the ability to examine CC with higher discrimination using
MLVA4 can provide insight into which BOX elements are changing. Serotype 7F (MLVA CC1
or ST191) largely diversifies due to BOX-10 and serotype 3 diversifies due to Spneu17. It is un-
known what the specific functions of these elements are, however it is known that VNTRs and
BOX elements play a role in bacterial competence and virulence and can influence gene expres-
sion downstream [30, 43]. VNTR loci with high diversity (e.g. Spneu17) would allow increased
discrimination within localised or short-term studies, whereas VNTR loci with low diversity
(e.g. BOX-02 and BOX-11) would allow identification of long term changes.
Fig 4. Comparison of discriminatory power for MLST, MLVA1, MLVA2 and MLVA4 when genotyping serotype 3 and serotype 7F in Queensland,
Australia. The population structure based on the respective genotypes determined by each genotyping method varies. MLST is considered the least
discriminatory as only one genotype is assigned to serotype 3 and serotype 7F, whereas MLVA4 provides increased discrimination by identifying a number of
genetically related but different genotypes.
doi:10.1371/journal.pone.0121870.g004
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In conclusion, we have developed a MLVA4 method for genotyping invasive S. pneumoniae.
The main advantage of this new method over other MLVA protocols is the ability to achieve
complete MLVA profiles for serotypes while also maintaining a highly discriminatory and fast
genotyping technique. Loci that failed to amplify were found to be serotype specific, which
may indicate that these BOX elements in these serotypes may be variable and have the capacity
to transpose. Further research is required to understand the VNTR genetics of these serotypes
as VNTRs and BOX loci are thought to play a role in virulence. MLVA4 is also more suitable
for genotyping S. pneumoniae than MLST as a more diverse population can be visualised and
allow accurate tracking of strains across the state. MLST may be more suitable for a national
study, rather than state. This study, establishes a population structure prior and post 13vPCV
introduction in Queensland, and it is expected that future monitoring will comprehensively
and accurately depict the changes in the pneumococcal population. The future perspective of
MLVA is that it will emerge as a cheap and fast genotyping method for localised and national
studies that can still be used in conjunction with the currently traditional and slower serotyping
and MLST methods for characterising S. pneumoniae.
Supporting Information
S1 Fig. Gel electrophoresis of serotype 33F S. pneumoniae strains. The white box highlights
a large>2000bp BOX-13 fragment in this serotype, identified for isolate number 105, 217, 219,
302, 303, 345, 365 and 367. Isolates 15, 150, 218 and 366 contain fragment lengths of 450bp for
BOX-13. A negative control (-ve) is included and size ladders are in beginning and end lanes
(100bp ladder and 123bp ladder, respectively.
(TIF)
S1 Table. Genotyping data results for MLST, MLVA1, MLVA2 and MLVA4 applied to
Queensland invasive S. pneumoniae isolates from 2007 to 2012.
(XLSX)
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